(Q46255359)

20 December 2017

title

The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells (English)

1 reference

20 December 2017

0 references

0 references

Takuro Hayashi

1

1 reference

20 December 2017

Kazuhide Adachi

series ordinal

2

1 reference

20 December 2017

Shigeo Ohba

series ordinal

3

1 reference

20 December 2017

Yuichi Hirose

series ordinal

4

1 reference

20 December 2017

publication date

13 August 2013

1 reference

20 December 2017

Journal of Neuro-Oncology

published in

1 reference

20 December 2017

volume

115

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

169-178

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s11060-013-1220-5

exact match

0 references

cites work

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Self-destruction and tolerance in resistance of mammalian cells to alkylation damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

MGMT: its role in cancer aetiology and cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Understanding and manipulating O6-methylguanine-DNA methyltransferase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

DNA repair and tumorigenesis: lessons from hereditary cancer syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

The G2-phase DNA-damage checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Forkhead transcription factors contribute to execution of the mitotic programme in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances ap

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Construction and characterization of a conditionally active version of the serine/threonine kinase Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

DNA damage-dependent nuclear dynamics of the Mre11 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Targeting Polo-like kinase in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Chromosomal passengers and the (aurora) ABCs of mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Histone H2A phosphorylation in DNA double-strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: an atypical tyrosine kinase with a key role in CDK1 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Mutations in Rb1 pathway-related genes are associated with poor prognosis in anaplastic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

Mismatch correction at O 6 -methylguanine residues in E. coli DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1220-5

A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy

21 January 2018

1 reference

12 December 2020

Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells.

1 reference

12 December 2020

Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.

1 reference

12 December 2020

The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells

1 reference

12 December 2020

Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.

1 reference

12 December 2020

Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity

1 reference

12 December 2020

Analysis of the p53 gene and its expression in human glioblastoma cells

1 reference

12 December 2020

p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells

1 reference

12 December 2020

Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival.

1 reference

12 December 2020

Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin.

1 reference

12 December 2020

Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells

1 reference

12 December 2020

Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis.

1 reference

12 December 2020

Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.

1 reference

12 December 2020

10.1007/S11060-013-1220-5

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

23943501

1 reference

20 December 2017